The Future of Life Sciences Comes to Philadelphia

Pennsylvania Bio’s event highlights new treatments and technology to reflect the rapidly-evolving landscape in healthcare

WHAT: Pennsylvania Bio, the statewide trade association representing Pennsylvania’s life sciences industry, is hosting Life Sciences Future on November 13 at the Pennsylvania Convention Center in Philadelphia. Life Sciences Future will focus on the newest scientific treatment advancements and highlight new technology and funding.

The dynamic agenda includes featured speakers Dr. Siddhartha Mukherjee, oncologist and Pulitzer Prize-winning author of The Emperor of All Maladies: A Biography of Cancer; Tom and Kari Whitehead, whose daughter Emily is a pediatric cancer survivor and the first pediatric patient in the world to receive genetically modified T cells that were engineered to fight cancer; and Dr. Michael Baird, the first DNA expert to testify in a U.S. court case.

The conference has been developed with the industry’s evolving landscape in mind, including biotechnology, pharmaceuticals, medical devices and diagnostics, healthcare IT, contract research organizations, research institutions, and the investment community. Pennsylvania Bio collaborated with representatives from each industry sector to design a meeting agenda that is engaging for all attendees.

  • WHEN: November 13, 2013 Dr. Baird is scheduled to speak at 12 p.m. Tom and Kari Whitehead are scheduled to speak at 12:20 p.m. Dr. Mukherjee is scheduled to speak at 12:45 p.m.
  • WHERE: Pennsylvania Convention Center, Broad Street Atrium Entrance, Philadelphia, PA 19107

Christopher P. Molineaux, President & CEO of Pennsylvania Bio, said, “We are looking forward to this new chapter in Pennsylvania Bio’s history where we develop our well-known annual conference into a gathering that more closely reflects the changing nature of the life sciences and healthcare industries. We pride ourselves on having evolved as a trade association to support the needs of our members. This year’s conference will continue to highlight that evolution. We hope to create an environment at the conference where our participants can network, share ideas, and work to solve some of the most challenging issues facing the life sciences community.”

Stephen Jannetta, Partner at Morgan Lewis, Chair of Life Sciences Future and Pennsylvania Bio Board Member, added: “The new model of the life sciences industry and evolving landscape present opportunities to link scientists, entrepreneurs, funding organizations, payers, providers and policy makers in creating solutions to grow and sustain the innovation infrastructure. Life Sciences Future offers attendees the opportunity to collaborate and help shape the future of the industry.”

In addition to the featured speakers, Life Sciences Future will include programming that gives attendees insight and best practices to stay at the forefront of the rapidly evolving industry.

For more information about Life Sciences Future and to register, visit

About Pennsylvania Bio

Pennsylvania Bio is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is the global leader in the biosciences by creating a cohesive community that unites our biotechnology, medical device, diagnostic, pharmaceutical, research, and financial strengths. More information is available at